SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
Clinical trial NCT02500914 · TERMINATED
Trial details
- NCT number
- NCT02500914
- Sponsor
- Stemcentrx
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2018-08-23
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.